Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

Long-term treatment with deupirfenidone (LYT-100) is generally well tolerated and may stabilize lung function in people with ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

One in five Albertans live with a lung condition, yet access to critical testing is limited in many rural and remote communities. This lack of access can contribute to delayed diagnosis and less ...

Tvardi Therapeutics has failed its first big test as a public company. | Tvardi Therapeutics has failed its first big test as a public company. Months after joining Nasdaq, the biotech has reported ...

Rx, a digital medicine company specialising in pulmonary care, has announced the launch of pDx, a mobile and web-accessible ...

A female infant presented with a month-long history of dry cough, along with two episodes of fever and increased work of ...

In this week’s edition of InnovationRx, we look at Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” ...

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...